EPISODE · Nov 20, 2024 · 10 MIN
Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
from Eyewire News: The Podcast · host Eyewire News
The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m